Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.
3.

ANCA-associated vasculitis with renal involvement: an outcome analysis.

Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.

Nephrol Dial Transplant. 2004 Jun;19(6):1403-11. Epub 2004 Apr 6.

PMID:
15069175
5.

[Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up].

Bolley R, Mistry-Burchardi N, Samtleben W.

Dtsch Med Wochenschr. 2000 Dec 15;125(50):1519-25. German.

PMID:
11190761
6.

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR; Pan-Thames Renal Research Group.

Am J Kidney Dis. 2003 Apr;41(4):776-84. Review.

PMID:
12666064
7.

IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.

Liu LJ, Chen M, Yu F, Zhao MH, Wang HY.

Nephrology (Carlton). 2008 Oct;13(7):629-35. doi: 10.1111/j.1440-1797.2008.00976.x. Epub 2008 Sep 3.

PMID:
18775059
8.

Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.

De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD.

Am J Kidney Dis. 1995 Mar;25(3):380-9.

PMID:
7872315
9.

Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.

Haubitz M, Koch KM, Brunkhorst R.

Nephrol Dial Transplant. 1998 Jul;13(7):1713-8.

PMID:
9681717
10.
11.

Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan.

Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, Hashimoto H, Nakao H, Nunoi H.

Clin J Am Soc Nephrol. 2006 Sep;1(5):1016-22. Epub 2006 Aug 2.

12.

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.

Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.

Rheumatology (Oxford). 2006 Nov;45(11):1432-6. Epub 2006 Apr 21.

PMID:
16632482
13.

Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis.

Kyndt X, Reumaux D, Bridoux F, Tribout B, Bataille P, Hachulla E, Hatron PY, Duthilleul P, Vanhille P.

Am J Med. 1999 May;106(5):527-33.

PMID:
10335724
16.

Relapses in patients with a systemic vasculitis.

Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, Emery P, Howie AJ, Bacon PA.

Q J Med. 1993 Dec;86(12):779-89.

PMID:
7906421
17.

Malignancy is increased in ANCA-associated vasculitis.

Pankhurst T, Savage CO, Gordon C, Harper L.

Rheumatology (Oxford). 2004 Dec;43(12):1532-5. Epub 2004 Aug 17.

PMID:
15316126
18.

[Clinical features of Wegener granulomatosis and microscopic polyangiitis in Chilean patients].

Cisternas M, Soto L, Jacobelli S, Marinovic MA, Vargas A, Sobarzo E, Saavedra J, Chauan K, Meléndez G, Foster C, Pacheco D, Wainstein E; Grupo de estudio de las vasculitis, Sociedad Chilena de Reumatología.

Rev Med Chil. 2005 Mar;133(3):273-8. Epub 2005 May 5. Spanish.

20.

[Wegener's granulomatosis and microscopic polyangiitis].

Pagnoux C.

Rev Prat. 2008 Mar 15;58(5):522-32. Review. French.

PMID:
18524109

Supplemental Content

Support Center